INTRODUCTION
Cancer is characterized by genomic alterations that lead to oncogene activation and/or tumor suppressor loss. These changes accumulate during tumor development and can be detected as translocations, amplifications, or deletions of chromosomal segments. Another major characteristic of cancer cells is their unlimited proliferative potential. This feature is dependent on the activation of a telomere maintenance mechanism upon exit from crisis (Hanahan and Weinberg, 2011) . During cell crisis, genome instability and telomere dysfunction have been primarily linked through the classical mechanism of breakage-fusionbridge cycle (BFB) first described by Barbara McClintock (McClintock, 1941) . In this chain of events, unprotected or broken telomeres can fuse to another chromosomal extremity via non-homologous end joining. Fusions create di-centric chromosomes that eventually break at random positions during mitosis, generating deletions and amplifications of chromosomal segments and more unprotected chromosome ends (Murnane, 2012) . This cycle persists until chromosomal extremities get stabilized by telomere addition via telomerase activation. In human, telomerase is activated in the majority of cancers. However, in a subset of tumors, mostly sarcomas, telomeres are maintained by a recombination/amplification mechanism termed alternative lengthening of telomeres (ALT) (Bryan et al., 1997) . These tumors typically harbor highly heterogeneous and complex karyotypes (Taylor et al., 2011) . The lack of apparent specific translocations makes it challenging to identify the mechanism driving tumorigenesis in these cancers. Efforts to characterize these tumors are thus currently limited to identifying specific gene expression signatures (Chibon et al., 2010) . Similarly, the mechanism underlying ALT activation and maintenance in these tumors is unknown. Because tumors in which telomerase is inhibited can activate ALT in mouse models (Hu et al., 2012) , it is critical to dissect this pathway to design efficient anti-cancer therapies targeting telomere maintenance. We previously showed that orphan nuclear receptors of the NR2C/F classes (TR2, TR4, COUP-TF1, COUP-TF2, and EAR2), which belong to the nuclear hormone receptor (NHR) family of transcription factors, are aberrantly associated with telomeres in a prototypic ALT(+) cell line (Dé jardin and Kingston, 2009 ). This finding was unexpected, as transcription factors usually associate with gene regulatory regions, and telomeres do not contain classical genes. Here, we address the biological relevance of this finding. We identify a critical role for these proteins in the ALT process and in active destabilization of the genome. We dissect the mechanism leading to their aberrant recruitment to telomeres, and we show that these proteins have a major architectural role: NR2C/F proteins can bridge together bound loci in the nuclear space. By promoting spatial proximity, NR2C/F proteins favor the telomere-telomere recombination necessary for ALT maintenance. Surprisingly, NR2C/F-driven spatial proximity also induces the tethering of telomeric chromatin to hundreds of regular NR2C/F-binding sites throughout the genome. This abnormal organization triggers the insertion of telomeric material to these sites, and this process depends on NR2C/F proteins. Insertions of telomeric DNA throughout the genome lead to the creation of potential common fragile sites that are known to be prone to breakage 
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Number of occurences in reads (legend continued on next page) and translocations. Because this mechanism of telomere-driven genome instability is fundamentally distinct from the BFB cycles and occurs as the consequence of the activation of a telomere maintenance mechanism, we name it targeted telomere insertions (TTI). In line with the role played by NR2C/F factors in TTI, we show that these proteins associate with telomeres in primary ALT tumors in situ and that this association correlates with the extent of karyotype rearrangements. Therefore, NR2C/F have a critical role in ALT and in the activation of TTI. We propose that this mechanism of telomere-driven genome instability induces heterogeneous genomes and contributes to the generation of complex karyotypes in ALT sarcomas (Taylor et al., 2011) .
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RESULTS
NR2C/F Factors Bind to Direct Repeats of a Variant Telomeric Motif
To get insights into the significance of NR2C/F binding to telomeres, we first examined how these factors are recruited. A mutant NR2C2 protein with point mutations disrupting DNA binding (Tanabe et al., 2007) fails to accumulate at telomeres (Figures S1A and S1B), suggesting that NR2C/F directly bind to DNA. NHR usually associate with DNA as dimers by binding to a composite sequence made of two half-sites (the 5 0 -A/GGGTCA-3 0 motif). Depending on the mutual orientation and spacing of these half-motifs, the full binding site varies extensively (Sandelin and Wasserman, 2005) . Since the NHR half-site is related to the canonical telomere basic repeat unit 5 0 -GGGTTA-3 0 , we hypothesized that NR2C/F could be recruited to ALT telomeres through binding to an iteration of the naturally occurring variant 5 0 -GGGTCA-3 0 (Allshire et al., 1989) .We thus analyzed by chromatin immunoprecipitation (ChIP) combined with high-throughput sequencing the DNA sequences associated with NR2C2 and NR2F2, those associated with the canonical telomere-binding protein TRF2 (de Lange, 2005) , and with HMBOX1, another DNA-binding protein that we previously identified at telomeres regardless of the maintenance mechanism (Dé jardin and Kingston, 2009 ). This analysis was performed in both ALT(+) and in ALT(À) cell lines (WI-38 VA13 2RA and HeLa 1.2.11 cells, respectively) using validated antibodies (Figures S2A, S4A, and S7A) . While TRF2 and HMBOX1 are enriched at both types of telomeres, NR2C2/F2 proteins bind only to ALT(+) telomeres (Figures 1A and S2A) , consistent with our original findings (Dé jardin and Kingston, 2009 ). Even when overexpressed, these factors cannot be detected at ALT(À) telomeres ( Figure S1D ), ruling out an effect due to differences in the expression level. To further characterize the binding mode of these factors, immunoprecipitated sequences were categorized according to their content in the canonical telomere motif GGGTTA (from one to eight occurrences in each 50-nt-long sequencing read). The canonical telomere motif has a similar distribution in the TRF2 and HMBOX1 libraries, implying similar binding specificity in both cell types ( Figure 1B ). In these libraries, the majority of enriched reads contains seven or eight occurrences of the canonical motif, suggesting that TRF2 and HMBOX1 bind to the canonical telomere sequence in vivo, as expected (Bilaud et al., 1997; Broccoli et al., 1997; Kappei et al., 2013) . In contrast, reads associated with NR2C2/F2 showed a different distribution of GGGTTA occurrences, indicating a distinct binding specificity ( Figure 1B) . To characterize the motifs that allow specific NR2C2/F2 binding, we analyzed these reads further (red brackets in Figure 1B ) and found that, among all possible sequences, the GGGTCA motif was specifically enriched in NR2C2/F2 reads ( Figure 1C ). This is in agreement with the classical sequence-specific binding mode for NHR and our original hypothesis (Benoit et al., 2006; Dé jardin and Kingston, 2009; Conomos et al., 2012) . Although less frequent (by $6-fold), the GGGTCA motif is also present in ALT(À) telomeres, indicating that the simple presence of the motif is not sufficient to promote NR2C/F recruitment. Thus, we analyzed the occurrence of the NHR motif in telomeric reads. GGGTCA is essentially found as a multimer in ALT(+) sequences and as a monomer in ALT(À) reads ( Figure 1D ), suggesting that NR2C/F cannot be recruited to single GGGTCA motif at telomeres. Since these data suggest a classical binding mode for NR2C/F factors, we searched for the full binding sites for these proteins. We identified the direct repeats DR0, DR6, and DR7 (two half-sites in the same orientation and separated by 0, 6, or 7 nucleotides) as the major NR2C/ F-binding sites at telomeres ( Figure 1E ), and these sites are, at least for DR0, $80-fold enriched in ALT(+)compared to ALT(À) telomeric DNA. Therefore, NR2C/F recruitment is promoted by the presence of DR0, 6, and 7 motifs specifically in ALT telomeres.
The Telomere Protein TRF2 Binds to Hundreds of NR2C/F Regions throughout the Genome of ALT Cells The aberrant recruitment of NR2C/F factors could suggest that telomeres potentially act as ''molecular sinks'' for these transcription factors in ALT cells. Titration could impinge on the binding and the regulation of NR2C/F targets, which would indirectly control ALT and/or tumorigenesis (Safe et al., 2014) . Therefore, we analyzed the genome-wide binding profile of NR2C2 and (legend continued on next page) NR2F2 and concluded that ALT(+) telomeres do not titrate these transcription factors since we identify more binding regions in ALT(+) than in ALT(À) genomes ( Figure 2A ). We also analyzed the genomic distribution of TRF2, as it supposedly binds not only to telomeres, but also to rare interstitial telomeric sequences (ITS) (Simonet et al., 2011) . ITS contain a various number of iterations of the GGGTTA motif explaining TRF2 recruitment and are well-characterized common fragile sites (CFS) (Bosco and de Lange, 2012) . Surprisingly in ALT(+) cells, we identified several hundreds of TRF2-binding sites ( Figure 2A ) that are not mapping to known ITS. However, most of these sites (75%) overlap with binding sites for NR2C2/F2 proteins ( Figures  2A and 2B ). Importantly, none of these regions were bound by TRF2 in ALT(À) cells, pointing to an ALT-specific binding mode for TRF2 ( Figure 2B ). In contrast, in ALT(À) cells, TRF2 binds only to 45 regions, 20 of which corresponded to known ITS often located in subtelomeric regions (Simonet et al., 2011) (Figures 2A-2C) . Interestingly, when we looked at the position of these sites with respect to genes, we found that the NR2C2 regions that also recruit TRF2 have a broad distribution and are usually located far from gene promoters ( Figure 2D ). In contrast, the TRF2-negative NR2C2 regions are principally located at gene transcription start sites. Moreover, the sequence content of these two populations is different. The classical promoter-bound NR2C2 regions are enriched in the expected motifs, in particular the ETS binding sequence (O'Geen et al., 2010) ( Figure 2E ). On the other hand, the non-genic NR2C2 regions bound by TRF2 lack the ETS motif but are highly enriched in the GGGTCA motif (81% reads). Remarkably, most of these sites ($87%) also lack the canonical telomere sequence, excluding a classical DNAmediated recruitment mechanism for TRF2. Thus, our data point to an unusual recruitment mode for TRF2 throughout the genome of ALT cells.
NR2C/F Proteins Induce Spatial Proximity of Their Binding Loci
A simple interaction between TRF2 and NR2C2/F2 only in ALT(+) cells is unlikely because a large number of NR2C2/F2 sites remain TRF2 free. Moreover, we failed to detect any interaction between TRF2 and NR2C/F proteins by coimmunoprecipitation (data not shown). Additionally, the absence of telomeric motifs at NR2C2/F2 sites likely excludes a direct TRF2 recruitment. Thus, we hypothesized that physical interactions between ALT telomeric material and endogenous NR2C/F-binding sites occur via NR2C/F proteins ( Figure 3A ). Accordingly, NR2C/F proteins would bridge ALT telomeres and extra-chromosomal telomeric material generated by the recombination process (Cesare and Griffith, 2004) together and to endogenous NR2C/F regions. By carrying over telomeric material, TRF2 is most probably crosslinked by formaldehyde ''in trans'' at endogenous NR2C/F regions, resulting in the appearance of enrichment peaks for TRF2 throughout the ALT genome at NR2C/F binding regions.
The same bridging feature would explain why telomeres extensively interact with each other in ALT cells. Classical methods to measure locus interactions like chromosome conformation capture (Dekker et al., 2002) are challenging for repetitive sequences like telomeres. Thus, to test telomere bridging by these factors, we used super-resolution three-dimensional structured illumination microscopy (3D-SIM), which improves spatial resolution by a factor of eight (Gustafsson et al., 2008) . We expressed the DNA-binding mutant NR2C2 protein in the SaOS-2 ALT cell line. This mutant acts as a dominant-negative for endogenous NR2C2 (Tanabe et al., 2007) , stripping it off telomeres (Figure S1C) . In SaOS-2 cells, NR2C2 is the only orphan nuclear receptor bound to telomeres, suggesting that no other NHR could compensate for NR2C2 loss. The expression of this mutant disrupts telomere-telomere interactions, as shown by super-resolution microscopy ( Figure 3B ). The number of telomeric clusters is reduced, and this is accompanied by an increase in the number of single detectable telomere signals (Figures 3B-3E, S3A, and S3B). On the other hand, expression of the mutant form of NR2C2 in HeLa 1.2.11 ALT(À) line has no effect on telomere number ( Figure S4C ). Similar results were obtained upon simultaneously knocking down NR2C1, NR2C2, and NR2F2 (NR2C/F) proteins in the WI38-VA13 ALT cell line ( Figures S4A and S4B ). Next, to evaluate bridging between telomeric material and nontelomeric NR2C/F regions, we developed an independent assay. In this approach, the sub-nuclear localization of a fluorescent plasmid DNA harboring NR2C/F DR0-binding sites can be tracked ( Figure S3C ). If our bridging hypothesis is valid, this plasmid should be targeted to ALT(+) telomeres, which concentrate NR2C/F proteins. In contrast, this plasmid should not co-localize with ALT(À) telomeres, which are devoid of NR2C/F factors. Indeed, despite the formation of large cytoplasmic aggregates in transfected cells, which were unavoidable, the plasmid is efficiently targeted to ALT(+), but not to ALT(À) telomeres ( Figure S3C ), whereas the control plasmid, not containing NR2C/F binding motifs, does not accumulate at telomeres. Moreover, this recruitment is NR2C/F dependent, as it disappears upon NR2C/F depletion by RNAi. Next, we measured whether NR2C/F tethering to a LacO transgenic locus nonhomologous to telomeric sequences is sufficient to drive the proximity of that locus to ALT telomeres. We used a transgenic U2-OS ALT cell line containing a single LacO array (Robinett et al., 1996) , in which we expressed a NR2C2-LacI fusion protein, able to bind to the LacO array in the absence of NHR binding motif. Tethering NR2C2-LacI to LacO leads to the extensive colocalization of the array to telomeric clusters (85% co-localization, Figure 3F ), consistent with the bridging feature of this factor. Unexpectedly, this also leads to the appearance of multiple LacO signals co-localized with telomeric signals (82% of cells were showing, on average, ten independent LacO foci), suggesting a dramatic instability of the LacO array upon interaction with ALT telomeres. Neither the tethering of GFP alone nor the tethering of NR2C2-LacI in a transgenic HeLa ALT(À) cell line harboring a single LacO array leads to its telomeric re-localization, or an amplification of LacO ( Figures 3F and S3D ). Altogether, our data demonstrate that NR2C/F binding is necessary for telomere-telomere proximity and for bridging bound loci to telomeres in the nuclear space. The amplification of LacO in the NR2C2 tethering experiment also suggests that bridging to ALT telomeres likely induces instability of the co-localized locus.
Telomere DNA Insertions at NR2C/F Regions in the Genome of ALT Cells Physical interactions between translocating loci is a major requirement for chromosomal translocations. In fact, translocations are primarily driven by the spatial organization of chromosomes in the nucleus (Misteli and Soutoglou, 2009 ). Chromosomal architecture must be highly perturbed in ALT cells because ALT genomes show complex chromosome rearrangements with multiple heterogeneous translocations (Guillou and Aurias, 2010; Jain et al., 2010; Lovejoy et al., 2012) . Since NR2C/F proteins can drive the physical interaction of bound loci and their apparent instability, we asked whether this feature could trigger instability at endogenous NR2C/F loci. We hypothesized that the genomic NR2C/F-binding sites interacting with telomeric material could also be sites of telomere sequence insertion. Telomeric DNA insertions at discrete genomic sites should yield composite sequencing reads that fail to be aligned to the reference genome. Thus, we focused our analysis on sequencing reads that had mismatches. In both ALT(+) and ALT(À) cell lines, $90% of the input libraries contain perfectly mappable reads, suggesting comparably high sequencing quality ( Figure S2B ). Likewise, reads mapping to repeated DNA are of comparably high quality ($88% aligned perfectly). However, while telomere reads from ALT(À) cells are also of high quality, telomere reads from ALT(+) cells are more degenerated and $25% cannot be aligned without allowing mismatches (Figure S2B ). To characterize this telomere specific discrepancy, we analyzed TRF2 libraries in both ALT(+) and ALT(À) cells and examined the sequence organization of the reads that could not be aligned to the reference genome. This showed that, among all possible random hexamers in rearranged sequences, there is a striking bias for the canonical GGGTTA and the variant GGGTCA motifs in ALT(+) samples ( Figure 4A ). This indicates that, specifically in ALT cells, reads containing these motifs are prone to rearrangements, regardless of their location in the genome. We extended this analysis to NR2C2, NR2F2, and HMBOX1 libraries. Reads in the NR2C2 and NR2F2 libraries are even more degenerated than in the TRF2 and HMBOX1 libraries ( Figures S2C and S2D ), suggesting that NHR binding regions are intrinsically more unstable. To get insights into the nature of these rearranged sequences, we analyzed their content in details using the strategy depicted in Figure 4B . Strikingly, these rearranged sequences are composed of a part mapping to unique genome regions and aberrant random additions of GGGTCA and/or GGGTTA sequences ( Figure 4B, bottom) , suggesting that they can result from insertions of telomeric DNA. These insertions do not occur at a precise position but are always located close to (<30 nt) DR0 motifs. The systematic presence of DR0 motifs in the non-rearranged portion of these reads points to the involvement of NR2C/F proteins in targeting the local rearrangement between ALT telomeric DNA and endogenous NR2C/F-binding sites. The few ALT(À) sequences that could not be mapped to the genome contain mostly singlenucleotide changes with no motif addition, suggesting that they did not arise from telomeric DNA insertion. In ALT cells, the rearranged reads map to 23 distinct genomic regions of which 19 ($82%) corresponded to TRF2-positive NR2C/F peaks ( Figure S6D ). This indicates that only a small subset (19/473, $4%) of NR2C/F regions able to recruit telomeric material are in fact loci for targeted telomeric insertions (TTI) in ALT cells.
NR2C/F-Driven Telomeric DNA Insertions at DNA Double-Stranded Breaks Are Involved in Chromosomal Translocations in ALT Cells
Artificial insertion of telomeric DNA inside genomes creates ITS, and this has been shown to promote chromosome rearrangements (Kilburn et al., 2001) . Because ITS are potential common fragile sites (Bosco and de Lange, 2012) , addition of telomeric DNA throughout the genome by TTI can be viewed as a source of genome instability. As TTI parallels ALT, it must be an ongoing mechanism in proliferating cells. To demonstrate that TTI is an active process in ALT cells, we tried to provoke telomere sequence addition throughout the genome. To this aim, we induced DNA double-strand breaks (DSB) by drug treatments or g irradiation and looked for telomere insertions at these sites by scoring the number of ITS signals on metaphase chromosome spreads. Detectable ITS are more frequent in untreated ALT(+) than ALT(À) chromosomes ($5-fold), in line with our sequencing data showing enrichment in telomeric sequences at genomic sites in ALT(+) cells ( Figure 5A ). Upon DSB induction, they double in ALT(+). No change was observed in ALT(À) chromosomes, suggesting that breaks are normally repaired without telomeric sequences added in this cell line (Murnane, 2012) . In ALT cells, $30% of both pre-existing and newly formed ITS sites are also bound by NR2C2 and 39% by TRF1, indicating their telomeric origin ( Figures 5B and 5C ). Consistent with previous data (Bosco and de Lange, 2012) fragile sites, as we observed increased breakage upon combined TRF1 knockdown and aphidicolin treatments ( Figure S5A ). TTI is NR2C/F dependent because no new ITS formed upon NR2C1, NR2C2, and NR2F2 silencing ( Figure 5C ). Moreover, NR2C/F-silenced cells have a significantly higher number of chromosomal fusions (arrowheads in Figure 5D ), mostly without detectable telomeric signal. These fusions greatly increase upon GTCAGGGTCAGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGGTAGGGT  GGTCAGGGTCGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGGTAGGGT  TTAGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGTC  AGGGTCAGGGGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGTC  ATCAGGGTCGGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGTC  TAGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGTCA  AGGGTCAGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGGTAGGGTCAG  CGGGTTGCGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGGTAGGGTCAG  GGGTTAGGGTCAGGGTCAGGGTTAGGGGTAGGGGTAGGGGTAGGGTCAGG  GGTCAGGGTCAGGGTCAGGGTTAGGGGTAGGGGTAGGGGTAGGGTCAGGG  TTAGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGTCAGGGTC  CAGGGTCAGGGTCAGGGCTAGGGTTAGGGGTAGGGGTAGGGTCAGGGTCA  TAGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGTCAGGGTCA  AGGGTTAGGGTTAGGGTTAGGGCTAGGGGTAGGGGTAGGGTCAGGGTCAG  AGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGGTAGGGTCAGGGTCAG  AGGGTTAGGGTTAGGGTTAGGGGCAGGGGTAGGGGTAGGGTCAGGGTCAG  TCAGGTCAGGTCAGGGTTAGGGTTAGGG TAGGGGTAGGGTCAGGGTCAGG  TTAGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGTCAGGGTCAGGGTC  TCAGGGTCAGGGTTAGGGTTAGGGTTAGGGGTAGGGTCAGGGTCAGGGTC  TAGGGTTAGGGTCAGGGTCAGGGTTAGGGGTAGGGTCAGGGTCAGGGTCA  TAGGGTTAGGGTTAGGGTCAGGGTCAGGGGTAGGGTCAGGGTCAGGGTCA  TAGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGTCAGGGTCAGGGTCA  AGGGTTAGGGTTAGGGTTAGGGTCAGGGGTAGGGTCAGGGTCAGGGTCAG  AGGGTTAGGGTTAGGGTTAGGGTTAGGGGTAGGGTCAGGGTCAGGGTCAG  GGTTCGGGTTCGGGTTAGGGGTTAGGGGGTAGGGTCAGGGTCAGGGTCAG  AGGGGTAGGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGGTTAGGGTCA  GGGGTAGGGGTAGGGTCAGGGTCAGGGTCAGGTCAGGTCAGGGTTAGGGT  GGGGTAGGGGTAGGGTCAGGGTCAGGGTCAGGGTTAGGGTCAGGGTTAGG  GGGGTAGGGGTAGGGTCAGGGTCAGGGGTTAGGGTCAGGGTCAGGGTCAG  GGGGTAGGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGTTAGGGTTAGG  GGGTAGGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGTTAGGGTCAGGG  GGTAGGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGGTTAGGGTCAGGG  GGTAGGGGTAGGGTCAGGGTCAGGGTTAGGGTTCGGGTTAGGGTTCGGGT  GGTAGGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGGTTAGGGTCAGGG  GTAGGGGTAGGGTCAGGGTCAGGGTCAGGTCAGGTCAGGGTTAGGGTTAG  TAGGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGTCAGGGGTTAGGGTC  AGGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGTCAGGGGTTAGGGTCA  AGGGGTAGGGTCAGGGTCAGGGTCAGGGGGATAGGGTTAGGGTTAGGGTT  GGGGTAGGGTCAGGGTCAGGGTCAGGGTCAGGGGTTAGGGTCAGGGTCAG DSB induction (up to 30% of fused chromosomes). This also suggests the involvement of NR2C/F proteins in preventing chromosomal fusions, a necessary condition for the maintenance of telomeric integrity in ALT cells. Similar results were also obtained in another ALT(+) cell line and with another DNA-damaging agent ( Figure S5B ), demonstrating that telomere sequence addition to broken chromosomal sites is common in ALT. Moreover, because NR2C/F depletion has no major effect on TRF1 and TRF2 levels ( Figure S4A ), this effect is unlikely due to a shelterin defect but suggests a protective role for NR2C/F factors on ALT telomeres. Since internal telomeric DNA has the inherent potential to form common fragile sites (CFS) in the human genome (Bosco and de Lange, 2012) and telomeres are fragile sites (Sfeir et al., 2009) , we reasoned that TTI should have the potential to form translocations. Such translocations could leave telomeric DNA between two chromosomal segments. DSB induced by g irradiation in the VA13 cell line resulted in 88 unique random break points on 693 analyzed chromosomes. 33% (29) of scored translocations have detectable telomeric signals at the translocation points between segments from distinct chromosomes, as measured by SKY-FISH and telomere FISH on metaphase spreads (Figures 5E and S6 and Table S1 ). Out of these 29 events, 13 do not involve terminal fusions, suggesting that TTI occurs frequently ($15% of scored translocations) when cells are challenged. Thus, telomeric DNA likely participates in chromosomal translocations in ALT cells.
Binding of NR2C/F Proteins to Telomeres Is a Hallmark of ALT in Tumors and Correlates with the Extent of Genome Rearrangements
To directly explore the link between NR2C/F association to telomeres, genome instability, and cancer in humans, we checked whether these proteins can also be found on telomeres in human primary tumors. We analyzed 180 primary sarcomas from the ''complexity index in sarcoma'' (CINSARC) signature collection (Chibon et al., 2010) by immunofluorescence and FISH on tissue microarrays (see Table S2 for tumors data). ALT nuclei contain structures called ALT-associated pro-myelocytic leukemia bodies (APB), in which the telomeric DNA is abnormally associated with the PML protein. The presence of APB is a diagnostic marker of ALT (Henson et al., 2005) . Accordingly, we scored 54.4% primary tumors analyzed as ALT(+) because these tumors have detectable APB. This is in line with the average ALT occurrence in sarcomas (Henson and Reddel, 2010) , validating our approach. The vast majority of ALT(+) tumors ($79%) also show telomeric accumulation of NR2F2 or NR2C2 ( Figures 6A and 6B) . We also analyzed healthy tissue sections surrounding 12 distinct tumors, and none (0/12) show NR2C2/F2 telomeric accumulation ( Figure S7 and Table S3 ). Thus, NR2C/F telomeric accumulations are cancer specific and do not predate tumor development. Importantly, the extent of NR2C/F association to telomeres correlates with the tumor grade (25% in grades 1 and 2, versus 61% in grade 3) (Figure 6C) . As tumor grade is a strong indicator of genome complexity in sarcomas (Chibon et al., 2010) , increased telomeric accumulation of NR2C/F proteins mirrors increased genome rearrangements. This suggests the involvement of NR2C/F proteins in generating complex karyotypes in human sarcomas.
DISCUSSION
Telomeres are important protective chromosomal structures that safeguard the genome. When telomeres are deprotected, classical BFB cycles ensue and lead to genome alterations. These alterations include deletions and amplifications of chromosomal segments typically observed in tumors ( Figure 7A ). The BFB cycles, although probably arising as a consequence of the initial loss of important genome surveillance mechanisms, favor the acquisition of oncogenic mutations or accelerate the loss of surveillance pathways that characterize transformed cells (Artandi et al., 2000) . Importantly, BFB cycles are stopped when broken chromosomal extremities are healed by the addition of telomeres. Chromosomal healing is usually achieved by the reactivation of telomerase, which is involved in the creation of functional telomeres. Therefore, it is thought that the acquisition of telomere maintenance by telomerase reactivation stabilizes the transformed genome and favors an unlimited proliferation of selected transformed cells. Here, we describe another mechanism of telomere-driven genome instability that actually occurs as a consequence of the activation of aberrant telomere maintenance ( Figure 7B) . In contrast to the genome stabilization conferred by telomerase, we show that ALT activation also directly destabilizes the genome, using an unexpected mechanism that we name targeted telomere insertion (TTI). We propose that TTI contributes to the complex karyotypes found in tumors or cell lines in which ALT is activated.
NR2C/F-Mediated Long-Distance Interactions
The massive recruitment of orphan nuclear receptors at telomeres in most ALT tumors or cell lines underlies a requirement to maintain a critical function. Consistently, loss of these proteins leads to defective telomere maintenance (Conomos et al., 2012; Dé jardin and Kingston, 2009 ) and chromosomal fusions ( Figure 5D ). We found no evidence for a role of NR2C/F proteins in transcribing telomeres (data not shown), but we show here that this function is structural. By inducing the proximity of their binding loci, NR2C/F proteins promote physical interactions of telomeric material, a necessary requirement for recombination. An unexpected consequence of this bridging ability is that telomeric material is also able to physically interact with non-telomeric NR2C2/F2-binding sites throughout chromosomes. This represents a further confirmation that bridging is a major feature of NR2C/F proteins. Intriguingly, not all NR2C/F genomic sites have this ability. Telomere-genome interactions usually occur at NR2C/F regions located at a distance from genes, while promoters bound by NR2C/F do not seem to be involved. We believe that the regions able to contact telomeres might be enhancers because these elements are known to interact at long distance and organize local chromosomal architecture (Smallwood and Ren, 2013) . How would regions bound by the same transcription factors be located in close physical proximity? We can think of at least two possibilities: either these proteins bind to a shared machinery/structure available in limiting amounts, or these factors have the ability to engage into homotypic interactions. In line with this, RXR proteins, which belong to the NR2B family of NHR, have been shown to be able to oligomerize in vitro (Chen and Privalsky, 1995) . The biological significance of such architectural ability is not totally clear, but the clustering of co-regulated regions (presumably bound by the same factors) is a recurrent feature. A benefit of clustering/compartmentalizing nuclear transactions is to increase the local concentration of reactive species to ensure the robustness of biological processes (Dé jardin, 2012).
Targeted Telomere Insertions: Implications for Genome Stability Another NHR, the androgen receptor (AR), was shown to drive the proximity of a subset of its target genes upon hormone induction (Lin et al., 2009; Mani et al., 2009) . Combined with genotoxic stress, proximity is required to promote cancer-specific translocations. We show here that the bridging function conferred upon NR2C/F binding drives telomere sequence additions throughout the genome upon genotoxic stress. Thus, we believe that, in cancer cells, the bridging ability of transcription factors, ordinarily used to modulate gene expression, is frequently diverted to trigger chromosomal translocations. In contrast to the well-defined translocation that AR controls in prostate cancer, TTI yields heterogeneous rearrangements. We think that TTI contributes to the appearance and maintenance of complex mutator phenotypes at least at two levels:
(1) the ongoing insertions of telomeric DNA at regulatory re- See also Figures S5 and S6 and Table S1 . See also Figure S7 and Tables S2 and S3. gions probably directly affect neighboring gene regulation, and (2) inserted telomeric DNA, which was shown to be prone to breakage, can contribute to elevated genomic instability. Our sequencing analysis could not allow us to measure the size of inserted telomeric DNA, but the detection of newly formed ITS by FISH ( Figure 5C ) suggests that these additions could extend to several kilobase pairs. Sarcomas in which ALT is active have been shown to systematically harbor complex karyotypes with non-specific translocations (Montgomery et al., 2004; Scheel et al., 2001 ). Although we cannot exclude that other mechanisms could be involved, we propose that TTI contributes to generating a subset of complex chromosomal rearrangements in these cancers. 
Structural-Illumination-Based Super-Resolution Microscopy and Telomere Clustering
Telomeres were labeled with a PNA probe using the FISH protocol described above. Full z stacks were acquired for each nucleus using the 1003 objective. Telomeric signals were counted on Z projections of nuclei. If more than one telomeric signal could be distinguished within a telomeric focus, then such focus was scored as a telomeric cluster.
Targeting LacO to Telomeres Cells were transfected either with GFP-LacI or with GFP-LacI and Flag-NR2C2-LacI, and the array was visualized either with the GFP or by LacO-specific FISH. Transfections were performed using the AMAXA nucleofector device using nucleofector reagent from Mirus according to manufacturers' instructions. Quantification of LacO localization to telomeres was performed 48 hr after transfection.
Transfections and Constructs
We performed triple NR2C/F knockdown because neither single nor double knockdowns had a strong impact on ALT telomeres, probably because of redundant function (Dé jardin and Kingston, 2009 
ITS Induction
Asynchronously growing cells were incubated with bleomycin (Calbiochem, 30 mU/ml) or etoposide (Sigma, 10 mM). After 2 hr, the drug-containing medium was replaced with fresh medium, and colcemid was added 43 hr after drug release to prepare chromosome spreads. We quantified the interstitial telomeric FISH signal on single and (rare) fused chromosomes. In triple Nr2c/f knockdown, because of the high frequency of chromosomal fusions, we quantified the interstitial telomeric FISH signal only from single (not fused) chromosomes to avoid counting fused chromosomes with residual telomere signal as ITS.
Aphidicolin Treatment and TRF1 Knockdown Cells were treated with low doses (0.3 mM) of Aphidicolin for 24 hr. Aphidicolin was added 24 hr after a second TRF1 RNAi transfection (two RNAi transfections within 48 hr). After 20 hr of Aphidicolin treatment, colcemid was added to medium to induce mitotic arrest. RNAi used for TRF1 knockdown was purchased from Dharmacon (SmartPool RNAi).
Western Blotting
Nuclear extracts from transfected cells were run on 12% Bis-Tris gels (Life Technologies [NP0341]) and transferred to PVDF membranes using a liquid transfer system for 2 hr at 300 mA. The membrane was blocked for 30 min at room temperature in 13 PBS containing 5% milk and then incubated with primary antibodies diluted 1/1,000 in the same buffer for 2 hr at room temperature, washed twice for 15 min in PBS-0.05%Tween 20, and incubated for 1 hr with secondary antibodies diluted 1/5,000 in 5% milk-PBS which was followed by two washes in PBS-0.05% Tween 20. 
ChIP Sequencing
Cells growing in monolayer were cross-linked in 1% formaldehyde/PBS for 10 min, washed twice in PBS, and scraped in PBS/0.05% Tween. Then cells were pelleted, washed in PBS, and incubated at 4 C in lysis buffer 1 for 10 min, then at room temperature in lysis buffer 2 for 10 min, dounced with a tight pestle, centrifuged, resuspended in lysis buffer 3 (1 ml/IP for $2 3 10 7 cells) and sonicated (12 pulses of 70% power, 15'' ON, 45'' OFF using a Misonix sonicator) to obtain chromatin fragments of 200 bp. Subsequently, chromatin was pre-cleared at 4 C with 10 ml/ml BSA-blocked Dynabeads (Life Technologies, a mix 1:1 of protein A and protein G beads) for 30 min and incubated at 4 C with 5 mg antibody/IP overnight. Chromatin was then incubated with magnetic beads at 4 C for 2 hr. Beads were washed five times with RIPA and once in TE with 50 mM NaCl. Chromatin was eluted from the beads by incubating in elution buffer with shaking for 30 min. Cross-linking was removed by overnight incubation at 65 C. After RNaseA and proteinase K treatments, the DNA was extracted with phenol:chloroform and ethanol precipitation. Isolated DNA was resuspended in water. ChIP experiments were performed four to six times independently for each antibody. Libraries were cloned and sequenced by Fasteris SA (Switzerland) using the Illumina strategy (HiSeq2000, single-end).
Antibodies anti-TRF2 (SantaCruz Biotechnology, sc-9143); anti-NR2C2-PPMX (PP-H0107B-00); anti-HMBOX1 (Abcam, ab97643); anti-NR2F2 (Abcam, ab50487).
Buffers Composition
Buffers used for ChIP have been described previously (Lee et al., 2006) .
Bioinformatic Analysis
Bioinformatic analysis is described in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures, seven figures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.cell.2015.01.044.
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